AAV-Based Gene Therapy Development: Some Real Concerns, Some 'Empty' Threats

被引：0
|
作者：
Gangurde, Rajiv [1 ]
机构：
[1] Parexel, Cell & Gene Therapy, Regulatory Strategy, Newton, MA USA
来源：
MOLECULAR THERAPY | 2024年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1049
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [21] AAV-BASED GENE THERAPY APPROACHES FOR THE TREATMENT OF CANAVAN DISEASE
    Jonquieres, G.
    Mersmann, N.
    Teahan, O.
    Klugmann, C. B.
    Harasta, A. E.
    Lutz, B.
    Housley, G. D.
    Klugmann, M.
    CYTOTHERAPY, 2013, 15 (04) : S12 - S12
  • [22] AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse
    Lee, E. K.
    Hu, C.
    Bhargava, R.
    Ponnusamy, R.
    Park, H.
    Novicoff, S.
    Rozengurt, N.
    Marescau, B.
    De Deyn, P.
    Stout, D.
    Schlichting, L.
    Grody, W. W.
    Cederbaum, S. D.
    Lipshutz, G. S.
    GENE THERAPY, 2013, 20 (08) : 785 - 796
  • [23] Development and validation of a recovery and purification process for recombinant AAV-based gene therapy vectors.
    Debelak, DJ
    Well, JR
    Eith, E
    Nichols, G
    Giugler, L
    Atkinson, EM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U126 - U126
  • [24] Development of an AAV-Based, RNA-Targeting Gene Therapy for the Treatment of Huntington's Disease
    Geddes, Claire E.
    Roth, Daniela
    Ta, Angeline
    Wilson, Alistair
    Gutierrez, Haydee
    Narayan, Nandini
    Angelis, Dimitrios
    Fang, Lydia
    Berlin, Aaron
    Nachtrab, Greg
    Gibbs, Dan
    Zisoulis, Dimitrios
    Batra, Ranjan
    MOLECULAR THERAPY, 2021, 29 (04) : 271 - 271
  • [25] AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse
    E K Lee
    C Hu
    R Bhargava
    R Ponnusamy
    H Park
    S Novicoff
    N Rozengurt
    B Marescau
    P De Deyn
    D Stout
    L Schlichting
    W W Grody
    S D Cederbaum
    G S Lipshutz
    Gene Therapy, 2013, 20 : 785 - 796
  • [26] Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes
    Kolesnik, Valeria V.
    Nurtdinov, Ruslan F.
    Oloruntimehin, Ezekiel Sola
    Karabelsky, Alexander V.
    Malogolovkin, Alexander S.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (03):
  • [27] DEVELOPING AAV-BASED GENE THERAPY FOR ADRENOLEUKODYSTROPHY (X-ALD)
    Ma, C.
    Zhang, Z.
    Feng, H.
    Li, C.
    Chen, L.
    Chen, J.
    Lai, L.
    Lian, Q.
    CYTOTHERAPY, 2019, 21 (05) : E14 - E14
  • [28] Low Endotoxin Control Strategy for an AAV-Based CNS Gene Therapy
    Stephansky, Stephen
    Chen, Li
    Cai, Ying
    MOLECULAR THERAPY, 2024, 32 (04) : 497 - 497
  • [29] Addressing the top five challenges to AAV-based gene therapy with ddPCR
    White, Mark
    White, Mark, 2021, Mary Ann Liebert Inc. (41):
  • [30] AAV-Based Gene Therapy Approaches for the Treatment of Giant Axonal Neuropathy
    Gray, Steven J.
    Shaw, Kelly A.
    McCown, Thomas J.
    Samulski, R. Jude
    MOLECULAR THERAPY, 2009, 17 : S317 - S317
12345